Markus Huembelin

Title: Innovations of Markus Huembelin

Introduction

Markus Huembelin is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the production of essential compounds through microbial processes. With a total of 2 patents, his work has implications for various industries, including pharmaceuticals and bioengineering.

Latest Patents

Huembelin's latest patents include innovative methods for the microbial production of Coenzyme Q-10. This invention focuses on enzymes involved in the synthesis of Coenzyme Q-10, specifically decaprenyl diphosphate (DPP) synthase and 4-hydroxybenzoate polyprenyltransferase. The patent also covers isolated DNA encoding these enzymes and methods for their application in microbial production. Another significant patent is for feedback-resistant mevalonate kinases. This invention relates to modified mevalonate kinases that exhibit reduced sensitivity to feedback inhibition. It includes polynucleotides encoding these modified enzymes, vectors comprising these polynucleotides, and host cells containing such vectors. The invention provides methods for producing the modified enzyme and for generating isoprenoid compounds.

Career Highlights

Throughout his career, Huembelin has worked with various companies, including DSM IP Assets B.V. and Isobionics B.V. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.

Collaborations

Some of his notable coworkers include Rual Lopez-Ulibarri and Renyuan Bai. Their collaborative efforts have further enhanced the research and development of the technologies associated with Huembelin's patents.

Conclusion

Markus Huembelin's contributions to biotechnology through his patents demonstrate his innovative spirit and commitment to advancing the field. His work in microbial production processes has the potential to impact various industries significantly.